FDA Drug Application (202624) for GANCICLOVIR by LUITPOLD PHARMS INC

Back to FDA Applications sponsored by LUITPOLD PHARMS INC

Application Number202624
Product Number001
FormINJECTABLE;INJECTION
DosageEQ 500MG BASE/VIAL
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AP Injectable aqueous solutions and, in certain instances, intravenous non-aqueous solutions
Reference Drug
Drug NameGANCICLOVIR
Active IngredientGANCICLOVIR SODIUM

Active IngredientCount
List of drugs with Active Ingredient GANCICLOVIR4
List of drugs with Active Ingredient GANCICLOVIR SODIUM3


Back to FDA Applications sponsored by LUITPOLD PHARMS INC